WindRose Health Investors has announced its acquisition of CardioOne. 

CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices.

WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

Terms of the acquisition were not disclosed.